Caspase-Family Inhibitor Z-VAD-FMK

Caspase family Inhibitor
Catalog #: 1010 | abID:

Product Details

Alternate Name Z-VAD-FMK, Z-VAD fluoromethylketone, Caspase-Family Inhibitor, pan-caspase inhibitor
Peptide Sequence Z-Val-Ala-Asp(OMe)-FMK
Appearance Liquid
Formulation 1010-100 In DMSO (2 mM); 1010-20C In DMSO (10 mM)
CAS # 187389-52-2
Molecular Formula C₂₂H₃₀N₃O₇F
Molecular Weight 467.5
Purity Single spot by TLC
InChi InChI=1S/C22H30FN3O7/c1-13(2)19(26-22(31)33-12-15-8-6-5-7-9-15)21(30)24-14(3)20(29)25-16(17(27)11-23)10-18(28)32-4/h5-9,13-14,16,19H,10-12H2,1-4H3,(H,24,30)(H,25,29)(H,26,31)
PubChem CID 5737
MDL Number MFCD01074990
Handling Protect from light and moisture
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


A synthetic peptide that irreversibly inhibits activity of caspase family proteases and blocks apoptosis. The inhibitor is designed as a methyl ester to facilitate cell permeability. The product can be used in both in vitro and in vivo studies. The inhibitor is designed as a methyl ester to facilitate cell permeability. (CAUTION: If the intended use is on purified or recombinant enzymes, esterase should be added to generate free carboxyl groups).

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.
Aurélie S. Leroyer  et al., The Involvement of CD146 and Its Novel Ligand Galectin-1 in Apoptotic Regulation of Endothelial Cells. J. Biol. Chem., Jan 2013; 288: 2571 - 2579
Liu J et al (2009) Infect. Immun.; 77: 837 - 849.
Dai Y et al (2008) Clin. Cancer Res.; 14: 7701 - 7710.
Liu J et al (2008) Infect. Immun. 76: 3784-3792.
Arai S et al. (2007) PNAS 104: 2289-2294.
For more citations of this product click here